Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02454881Phase 4Completed
Phase 4, randomised trial of dexmedetomidine in postoperative pain (4 arms), sponsored by Turku University Hospital. Primary endpoint: Change in opioid consumption at 24 hours. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02454881.